777 related articles for article (PubMed ID: 15368589)
1. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
3. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E
Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Tan L; Xu B; Liu R; Liu H; Tan H; Huang W
Cancer Biol Ther; 2010 Mar; 9(5):350-7. PubMed ID: 20061812
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
[TBL] [Abstract][Full Text] [Related]
6. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
[TBL] [Abstract][Full Text] [Related]
7. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.
Diaz RM; Bateman A; Emiliusen L; Fielding A; Trono D; Russell SJ; Vile RG
Gene Ther; 2000 Oct; 7(19):1656-63. PubMed ID: 11083474
[TBL] [Abstract][Full Text] [Related]
8. [The construction of recombinant type I herpes simplex virus carrying GALV.fus gene and its antitumor effect in nude mice].
Zhu M; Yang JR; Jiang YQ; Chen SF; Fu XP; Tian ZD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):152-6. PubMed ID: 21500543
[TBL] [Abstract][Full Text] [Related]
9. Properties of Sindbis virus vectors produced with a chimeric split helper system.
Ketola A; Schlesinger S; Wahlfors J
Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
[TBL] [Abstract][Full Text] [Related]
11. Reducing cytotoxicity induced by Sindbis viral vectors.
Sawai K; Ikeda H; Ishizu A; Meruelo D
Mol Genet Metab; 1999 May; 67(1):36-42. PubMed ID: 10329021
[TBL] [Abstract][Full Text] [Related]
12. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.
Ohno K; Sawai K; Iijima Y; Levin B; Meruelo D
Nat Biotechnol; 1997 Aug; 15(8):763-7. PubMed ID: 9255791
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector.
Sawai K; Meruelo D
Biochem Biophys Res Commun; 1998 Jul; 248(2):315-23. PubMed ID: 9675133
[TBL] [Abstract][Full Text] [Related]
15. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of Sindbis viral vectors.
Tseng JC; Levin B; Hirano T; Yee H; Pampeno C; Meruelo D
J Natl Cancer Inst; 2002 Dec; 94(23):1790-802. PubMed ID: 12464651
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of recombinant alphaviruses as vectors in gene therapy.
Wahlfors JJ; Zullo SA; Loimas S; Nelson DM; Morgan RA
Gene Ther; 2000 Mar; 7(6):472-80. PubMed ID: 10757020
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
Kim T; Leibfried-Rutledge ML; First NL
Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
20. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
